Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-03-12FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for fluphenazine hydrochloride (generic) from PAI Holdings, LLC dba PAI Pharma, indicating an ap…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses
A pharmacogenetic investigation of antipsychotics in schizophrenia and schizoaffective disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-02-26Clinical Trial Update: Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia [Phase 2, Phase 3]
A Phase 2/Phase 3 trial investigated adding an ampakine to clozapine, olanzapine, or risperidone in patients with schizophrenia; the study h…
-
CLINICAL_TRIALS trial_result · 2009-02-24Clinical Trial Update: Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia [NA]
This completed clinical trial evaluated modafinil augmentation for excessive daytime sleepiness and negative symptoms in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2009-02-24Clinical Trial Update: Risperidone Maintenance Treatment in Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating risperidone for maintenance treatment in schizophrenia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2009-02-24Clinical Trial Update: A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia [Phase 2]
Pfizer's 6-week Phase 2 multicenter trial of varenicline tartrate for cognitive impairment in schizophrenia has been withdrawn.
-
FDA approval · 2009-02-24FDA Approved: RISPERIDONE — Original Application (Amici Pharma, Inc.)
FDA approves the original application for a risperidone generic from Amici Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis [Phase 2]
A Phase 2 pilot study evaluating a modified cognitive behavioral therapy approach for adolescents with early onset psychosis.
-
CLINICAL_TRIALS research · 2009-02-19Clinical Trial Update: Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function [NA]
This clinical trial update discusses genetic expression in schizophrenia patients treated with SSRI augmentation and its relation to clinica…
-
CLINICAL_TRIALS research · 2009-02-18Clinical Trial Update: Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia [Phase 4]
This Phase 4 randomized trial compares two treatment strategies for schizophrenia: clozapine plus aripiprazole versus clozapine plus haloper…
-
CLINICAL_TRIALS trial_result · 2009-02-12Clinical Trial Update: Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia [Phase 1, Phase 2]
Phase 1/2 trial update evaluating modafinil as an adjunct to standard treatment to improve cognitive functioning in patients with schizophre…
-
CLINICAL_TRIALS trial_result · 2009-02-06Clinical Trial Update: Cognitive Functioning Related to Job Tenure Among Patients With Schizophrenia
A completed clinical trial examining cognitive functioning related to job tenure in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: The Effect of Intranasal Administration of Oxytocin on Empathic Abilities. [Phase 2]
Phase 2 trial evaluating whether intranasal oxytocin improves empathic abilities in people with schizophrenia; the trial status is currently…
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia [Phase 4]
This Phase 4 clinical trial compared the cost-effectiveness of olanzapine versus haloperidol for schizophrenia (including schizoaffective di…
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: Recovery Group Pilot [NA]
Kaiser Permanente sponsored the Recovery Group Pilot trial, which has completed. The trial targeted bipolar disorder, schizophrenia, and sch…
-
FDA approval · 2009-01-30FDA Approved: RISPERIDONE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approves ANI Pharmaceuticals' original application for risperidone, adding a generic version of the antipsychotic.
-
FDA approval · 2009-01-29FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for HALOPERIDOL DECANOATE from Mylan Institutional LLC, a long-acting injectable antipsychotic used …
-
CLINICAL_TRIALS safety_alert · 2009-01-27Clinical Trial Update: Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment
A clinical trial update reports changes in heart rhythms associated with antipsychotic drug treatment, highlighting potential cardiac safety…
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Escitalopram in Schizophrenia in OCD- Open Label Study [Phase 4]
Open-label Phase 4 trial evaluating escitalopram in schizophrenia with comorbid obsessive-compulsive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study [Phase 4]
An open-label Phase 4 trial evaluating tolerability and efficacy of high-dose escitalopram in patients with obsessive-compulsive disorder an…
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Donepezil Double Blind Trial for ECT Memory Disfunction [Phase 4]
Phase 4 clinical trial update on a double-blind study of donepezil for memory dysfunction after electroconvulsive therapy in schizophrenia, …
-
FDA approval · 2009-01-23FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA has approved a supplemental application for thioridazine hydrochloride from Mylan Pharmaceuticals, indicating a regulatory change to…
-
FDA approval · 2009-01-23FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for fluphenazine hydrochloride by Lannett, adding another generic version of this antipsychotic to t…
-
FDA approval · 2009-01-21FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic combination product PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE from Mylan Pharmace…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: The Effects of Risperidone and Olanzapine on Thinking [Phase 4]
Phase 4 clinical trial update assessing the effects of risperidone and olanzapine on thinking/cognition in people with schizophrenia or psyc…